These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25865415)

  • 1. Analgesia and unwanted benzodiazepine effects in point-mutated mice expressing only one benzodiazepine-sensitive GABAA receptor subtype.
    Ralvenius WT; Benke D; Acuña MA; Rudolph U; Zeilhofer HU
    Nat Commun; 2015 Apr; 6():6803. PubMed ID: 25865415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genuine antihyperalgesia by systemic diazepam revealed by experiments in GABAA receptor point-mutated mice.
    Knabl J; Zeilhofer UB; Crestani F; Rudolph U; Zeilhofer HU
    Pain; 2009 Feb; 141(3):233-238. PubMed ID: 19091469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihyperalgesia by α2-GABAA receptors occurs via a genuine spinal action and does not involve supraspinal sites.
    Paul J; Yévenes GE; Benke D; Di Lio A; Ralvenius WT; Witschi R; Scheurer L; Cook JM; Rudolph U; Fritschy JM; Zeilhofer HU
    Neuropsychopharmacology; 2014 Jan; 39(2):477-87. PubMed ID: 24045508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha2-gamma-Aminobutyric acid (GABA)A receptors are the molecular substrates mediating precipitation of narcosis but not of sedation by the combined use of diazepam and alcohol in vivo.
    Täuber M; Calame-Droz E; Prut L; Rudolph U; Crestani F
    Eur J Neurosci; 2003 Nov; 18(9):2599-604. PubMed ID: 14622161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain.
    Di Lio A; Benke D; Besson M; Desmeules J; Daali Y; Wang ZJ; Edwankar R; Cook JM; Zeilhofer HU
    Neuropharmacology; 2011 Mar; 60(4):626-32. PubMed ID: 21145329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.
    Rudolph U; Crestani F; Benke D; Brünig I; Benson JA; Fritschy JM; Martin JR; Bluethmann H; Möhler H
    Nature; 1999 Oct; 401(6755):796-800. PubMed ID: 10548105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of pathological pain through specific spinal GABAA receptor subtypes.
    Knabl J; Witschi R; Hösl K; Reinold H; Zeilhofer UB; Ahmadi S; Brockhaus J; Sergejeva M; Hess A; Brune K; Fritschy JM; Rudolph U; Möhler H; Zeilhofer HU
    Nature; 2008 Jan; 451(7176):330-4. PubMed ID: 18202657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clobazam metabolite N-desmethyl clobazam is an α2 preferring benzodiazepine with an improved therapeutic window for antihyperalgesia.
    Ralvenius WT; Acuña MA; Benke D; Matthey A; Daali Y; Rudolph U; Desmeules J; Zeilhofer HU; Besson M
    Neuropharmacology; 2016 Oct; 109():366-375. PubMed ID: 27392635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoring the spinal pain gate: GABA(A) receptors as targets for novel analgesics.
    Zeilhofer HU; Ralvenius WT; Acuña MA
    Adv Pharmacol; 2015; 73():71-96. PubMed ID: 25637438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABAA receptor subtype-selective modulators. II. α5-selective inverse agonists for cognition enhancement.
    Atack JR
    Curr Top Med Chem; 2011; 11(9):1203-14. PubMed ID: 21050171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GABAA receptor subtype-selective modulators. I. α2/α3-selective agonists as non-sedating anxiolytics.
    Atack JR
    Curr Top Med Chem; 2011; 11(9):1176-202. PubMed ID: 21050172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABA
    Müller Herde A; Benke D; Ralvenius WT; Mu L; Schibli R; Zeilhofer HU; Krämer SD
    Neuroimage; 2017 Apr; 150():279-291. PubMed ID: 28192273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological and antihyperalgesic properties of the novel α2/3 preferring GABA
    Fischer BD; Schlitt RJ; Hamade BZ; Rehman S; Ernst M; Poe MM; Li G; Kodali R; Arnold LA; Cook JM
    Brain Res Bull; 2017 May; 131():62-69. PubMed ID: 28267561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sh-I-048A, an in vitro non-selective super-agonist at the benzodiazepine site of GABAA receptors: the approximated activation of receptor subtypes may explain behavioral effects.
    Obradović ALj; Joksimović S; Poe MM; Ramerstorfer J; Varagic Z; Namjoshi O; Batinić B; Radulović T; Marković B; Roth BL; Sieghart W; Cook JM; Savić MM
    Brain Res; 2014 Mar; 1554():36-48. PubMed ID: 24472579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP003 is a non-selective benzodiazepine site agonist that induces anxiolysis via α2GABA
    Neumann E; Ralvenius WT; Acuña MA; Rudolph U; Zeilhofer HU
    Neuropharmacology; 2018 Dec; 143():71-78. PubMed ID: 30240781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha1- and alpha2-containing GABAA receptor modulation is not necessary for benzodiazepine-induced hyperphagia.
    Morris HV; Nilsson S; Dixon CI; Stephens DN; Clifton PG
    Appetite; 2009 Jun; 52(3):675-683. PubMed ID: 19501766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement of alpha5-GABAA receptors for the development of tolerance to the sedative action of diazepam in mice.
    van Rijnsoever C; Täuber M; Choulli MK; Keist R; Rudolph U; Mohler H; Fritschy JM; Crestani F
    J Neurosci; 2004 Jul; 24(30):6785-90. PubMed ID: 15282283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neural basis of benzodiazepine reward: requirement for α2 containing GABAA receptors in the nucleus accumbens.
    Engin E; Bakhurin KI; Smith KS; Hines RM; Reynolds LM; Tang W; Sprengel R; Moss SJ; Rudolph U
    Neuropsychopharmacology; 2014 Jul; 39(8):1805-15. PubMed ID: 24553732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABAA α5 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085.
    de Lucas AG; Ahring PK; Larsen JS; Rivera-Arconada I; Lopez-Garcia JA; Mirza NR; Munro G
    Biochem Pharmacol; 2015 Feb; 93(3):370-9. PubMed ID: 25542996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzodiazepine-site pharmacology on GABAA receptors in histaminergic neurons.
    May AC; Fleischer W; Kletke O; Haas HL; Sergeeva OA
    Br J Pharmacol; 2013 Sep; 170(1):222-32. PubMed ID: 23799902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.